Cargando…

The Cost-Effectiveness of an Advanced Hybrid Closed-Loop System in People with Type 1 Diabetes: a Health Economic Analysis in Sweden

INTRODUCTION: Swedish National Diabetes Registry data show a correlation of improved glycemic control in people with type 1 diabetes (T1D) with increased use of diabetes technologies over the past 25 years. However, novel technologies are often associated with a high initial outlay. The aim of the p...

Descripción completa

Detalles Bibliográficos
Autores principales:	Jendle, Johan, Buompensiere, M. I., Holm, A. L., de Portu, S., Malkin, S. J. P., Cohen, O.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Springer Healthcare 2021
Materias:	Original Research
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8519965/ https://www.ncbi.nlm.nih.gov/pubmed/34596879 http://dx.doi.org/10.1007/s13300-021-01157-0

Ejemplares similares

A Response to: Letter to the Editor with Regard to the Cost-Effectiveness of an Advanced Hybrid Closed-Loop System in People with Type 1 Diabetes: A Health Economic Analysis in Sweden
por: Jendle, J., et al.
Publicado: (2022)

Randomised controlled trial of Advanced Hybrid Closed Loop in an Adult Population with Type 1 Diabetes (ADAPT): study protocol and rationale
por: de Portu, Simona, et al.
Publicado: (2022)

Cost-Effectiveness Analysis of Sensor-Augmented Insulin Pump Therapy with Automated Insulin Suspension Versus Standard Insulin Pump Therapy in Patients with Type 1 Diabetes in Sweden
por: Jendle, Johan, et al.
Publicado: (2017)

Costs of diabetes complications: hospital-based care and absence from work for 392,200 people with type 2 diabetes and matched control participants in Sweden
por: Andersson, Emelie, et al.
Publicado: (2020)

Achieving Good Glycemic Control Early After Onset of Diabetes: A Cost-Effectiveness Analysis in Patients with Type 1 Diabetes in Sweden
por: Jendle, Johan, et al.
Publicado: (2017)

Smart Insulin Pens are Associated with Improved Clinical Outcomes at Lower Cost Versus Standard-of-Care Treatment of Type 1 Diabetes in Sweden: A Cost-Effectiveness Analysis
por: Jendle, Johan, et al.
Publicado: (2020)

Hybrid Closed-loop to Manage Gastroparesis in People With Type 1 Diabetes: a Case Series
por: Daly, Aideen, et al.
Publicado: (2021)

Cost-Effectiveness of the FreeStyle Libre(®) System Versus Blood Glucose Self-Monitoring in Individuals with Type 2 Diabetes on Insulin Treatment in Sweden
por: Jendle, Johan, et al.
Publicado: (2021)

Quality of life in the course of a one-year use of an advanced hybrid closed-loop system in adults with type 1 diabetes previously naïve to advanced diabetes technology
por: Cyranka, Katarzyna, et al.
Publicado: (2023)

The burden of poor glycaemic control in people with newly diagnosed type 2 diabetes in Sweden: A health economic modelling analysis based on nationwide data
por: Hellgren, Margareta, et al.
Publicado: (2021)

Training and Support for Hybrid Closed-Loop Therapy
por: Boughton, Charlotte K., et al.
Publicado: (2020)

Advanced Hybrid Closed Loop users’ satisfaction of telemedicine and telenursing in pediatric and young adult type 1 diabetes
por: Bassi, Marta, et al.
Publicado: (2023)

Cost-Effectiveness of Intermittently Scanned Continuous Glucose Monitoring Versus Advanced Hybrid Closed-Loop Systems in Type 1 Diabetes: Comment on Jendle et al.
por: Levrat-Guillen, Fleur, et al.
Publicado: (2022)

Pediatric Type 1 Diabetes: Is Age at Onset a Determining Factor in Advanced Hybrid Closed-Loop Insulin Therapy?
por: Lendínez-Jurado, Alfonso, et al.
Publicado: (2023)

Impact on glucometric variables and quality of life of the advanced hybrid closed‐loop system in pediatric and adolescent type 1 diabetes
por: Lendínez‐Jurado, Alfonso, et al.
Publicado: (2023)

Virtual training on the hybrid close loop system in people with type 1 diabetes (T1D) during the COVID-19 pandemic
por: Gómez, Ana M., et al.
Publicado: (2021)

One Year Real-World Use of the Control-IQ Advanced Hybrid Closed-Loop Technology
por: Breton, Marc D., et al.
Publicado: (2021)

Advanced hybrid closed-loop system: first successful clinical case after total pancreatectomy
por: Rizzi, A., et al.
Publicado: (2021)

Burden of established cardiovascular disease in people with type 2 diabetes and matched controls: Hospital‐based care, days absent from work, costs and mortality
por: Persson, Sofie, et al.
Publicado: (2022)

Six-Month Effectiveness of Advanced vs. Standard Hybrid Closed-Loop System in Children and Adolescents With Type 1 Diabetes Mellitus
por: Tornese, Gianluca, et al.
Publicado: (2021)

Carbohydrate Tolerance Threshold for Unannounced Snacks in Children and Adolescents With Type 1 Diabetes Using an Advanced Hybrid Closed-Loop System
por: Tornese, Gianluca, et al.
Publicado: (2022)

Patient reported outcome measures in children and adolescents with type 1 diabetes using advanced hybrid closed loop insulin delivery
por: Gianini, Ana, et al.
Publicado: (2022)

Inequalities in pharmacologic treatment of spasticity in Sweden – health economic consequences of closing the treatment gap
por: Forsmark, Annabelle, et al.
Publicado: (2020)

Optimizing a Hybrid Closed Loop System in Type 1 Diabetes: A Case Report
por: Petrovski, Goran, et al.
Publicado: (2018)

Commercial hybrid closed-loop systems available for a patient with type 1 diabetes in 2022
por: Seget, Sebastian, et al.
Publicado: (2023)

Effect of 6 months hybrid closed-loop insulin delivery in young people with type 1 diabetes: a randomised controlled trial protocol
por: de Bock, Martin, et al.
Publicado: (2018)

Closed loop control for type 1 diabetes
por: Kovatchev, Boris
Publicado: (2011)

Closed-loop bioelectronic medicine for diabetes management
por: Güemes Gonzalez, Amparo, et al.
Publicado: (2020)

Advances in closed-loop deep brain stimulation devices
por: Parastarfeizabadi, Mahboubeh, et al.
Publicado: (2017)

An overview of advancements in closed-loop artificial pancreas system
por: Dermawan, Doni, et al.
Publicado: (2022)

Benefits and Challenges of Current Closed-Loop Technologies in Children and Young People With Type 1 Diabetes
por: Fuchs, Julia, et al.
Publicado: (2021)

A Comparison of Two Hybrid Closed-Loop Systems in Italian Children and Adults With Type 1 Diabetes
por: Bassi, Marta, et al.
Publicado: (2022)

Safety and Glycemic Outcomes During the MiniMed™ Advanced Hybrid Closed-Loop System Pivotal Trial in Adolescents and Adults with Type 1 Diabetes
por: Carlson, Anders L., et al.
Publicado: (2022)

Economic consequences of migraine in Sweden and implications for the cost-effectiveness of onabotulinumtoxinA (Botox) for chronic migraine in Sweden and Norway
por: Hansson-Hedblom, Amanda, et al.
Publicado: (2020)

Glycemic control in people with type 1 diabetes using a hybrid closed loop system and followed by telemedicine during the COVID-19 pandemic in Italy
por: Longo, Miriam, et al.
Publicado: (2020)

Medtronic MiniMed 670G Hybrid Closed-Loop System
por: Knebel, Tory, et al.
Publicado: (2019)

Transitioning of People With Type 1 Diabetes From Multiple Daily Injections and Self-Monitoring of Blood Glucose Directly to MiniMed 780G Advanced Hybrid Closed-Loop System: A Two-Center, Randomized, Controlled Study
por: Matejko, Bartłomiej, et al.
Publicado: (2022)

Evaluating the Clinical and Economic Outcomes Associated with Poor Glycemic Control in People with Type 1 Diabetes in the Netherlands
por: Moes, Robert Gerald Jan, et al.
Publicado: (2023)

Day and night glucose control using a hybrid closed loop system for the management of type 1 diabetes
por: de Bock, Martin, et al.
Publicado: (2015)

Clinician Experiences With Hybrid Closed Loop Insulin Delivery Systems in Veterans With Type 1 Diabetes: Qualitative Study
por: Mizokami-Stout, Kara, et al.
Publicado: (2023)

Cannot write session to /tmp/vufind_sessions/sess_r923i81lgmu0nf7f90rg9tf4ud